Adenovirus treatment in transplant patients

    • Chimerix, Inc.

      A first potential indication in treatment of adenovirus in pediatric transplant builds on the benefits we believe oral brinci will bring to patient care. In parallel, IV brincidofovir is progressing in adult transplant recipients, and we anticipate interim Phase 2 data in the second half of 2018,” continued Dr. Berrey.


    • [DOC File]June 15, 2000 Bethany B

      https://info.5y1.org/adenovirus-treatment-in-transplant-patients_1_3aa6c2.html

      Gammaherpesvirus-induced pneumonitis in murine bone marrow transplant model is associated with effects of transforming growth factor beta on T cells. ATS International Conference, Denver, CO, May 15-18, 2011. 72. Moore, BB, Fry, CD, Wilke, CA and GB Toews. Circulating monocytes in idiopathic pulmonary fibrosis (IPF) patients express TLR9 and CD206.


    • New Application - ACGME Home

      Obtaining the skills needed to care for patients in all the phases of transplant care, including evaluation and indications, pre-transplant management, peri-operative care, immediate post-operative critical care, and the specifics of short-and long-term post-transplant medical management [PR IV.B.1.b).(1).(g)]


    • [DOC File]CONSENT FORM - Emmes

      https://info.5y1.org/adenovirus-treatment-in-transplant-patients_1_d3f3cb.html

      Adenovirus is a virus that just causes symptoms of a common cold normally but which can cause serious life-threatening infections in patients who have weak immune systems. ... This treatment with specially trained T cells (called CTLs) has had activity against these viruses when the cells are made from the transplant donor. ... types of T cells ...


    • Chimerix, Inc.

      This study is targeting enrollment of 141 pediatric allogeneic hematopoietic cell transplant (HCT) recipients with confirmed clinically significant adenovirus (AdV) infection. Patients are randomized 2:1 to receive short-course oral brincidofovir (BCV) or the local standard-of-care (SOC) at approximately 30 sites across Europe and the United ...


    • [DOC File]Bronchiolitis obliterans (BO) is an uncommon and severe ...

      https://info.5y1.org/adenovirus-treatment-in-transplant-patients_1_ec2c83.html

      A case report describes successful treatment of BO in a bone marrow transplant patient with TNF-α blockade (Infliximab). Other studies suggest a potential role for maintenance of macrolide therapy in the treatment of bronchiolitis obliterans where the anti-inflammatory properties and ability to reduce inflammatory mediators of interleukin IL-8 ...


    • [DOCX File]Antiviral treatment of severe non-influenza respiratory ...

      https://info.5y1.org/adenovirus-treatment-in-transplant-patients_1_39cd94.html

      It has been used experimentally in a small number of immunocompromised patients with severe adenovirus disease and a larger number with asymptomatic adenovirus infection as a pre-emptive treatment, but larger-scale randomised controlled trials are needed [48,49].


Nearby & related entries: